Catalyst Wire Dossier Catalyst Wire Dossier

Bridion (Sugammadex)

Sugammadex · Merck & Co.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bridion (Sugammadex), covering 2018-03-05 to 2018-03-05. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Sugammadex for Muscle Motor Response and Awareness in Intraoperative Wakeup [Phase 4]

See pricing